Skip to main content

Day: December 11, 2019

PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors

PRINCETON, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that James Loughlin has resigned from the Company’s board of directors to focus on his health and family, effective immediately. He joined PDS Biotech’s board of directors in March 2019, following the merger with Edge Therapeutics, where he served on the board since November 2011.“On behalf of our board of directors, I would like to thank Jim for his service and contributions to the Company. Jim has been a trusted colleague and advisor and we wish him all the best,” said Dr. Frank Bedu-Addo, CEO of PDS Biotechnology. “We have initiated the process to identify a high caliber...

Continue reading

Kimball Electronics, Inc. Announces Release of Inaugural Environmental, Social and Governance (ESG) Report

JASPER, Ind., Dec. 11, 2019 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (NASDAQ: KE), (the “Company”), today announced the release of its first-ever Environmental, Social and Governance (ESG) Report.The report highlights the long-term environmental, social and governance principles and practices designed to support the Company’s commitment to sustaining “lasting relationships” and achieving “global success” with its stakeholders wherever Kimball Electronics’ touch is felt throughout the world.“I’m excited about our inaugural ESG report. I hope it provides insightful information to give a greater appreciation for the goodness of our company and our employees,” says Don Charron, Chairman of the Board and Chief Executive Officer.Mr. Charron continued, “This is a new report, but what is not new is our demonstrated commitment to our...

Continue reading

Assembly Biosciences Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB) (“Assembly”), today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Assembly also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the proposed offering are to be sold by Assembly. Jefferies LLC, SVB Leerink LLC and William Blair & Company, L.L.C. are acting as joint bookrunning managers for the offering.The securities described above are being offered pursuant to a shelf registration...

Continue reading

Wabash National Director Ann Murtlow Named Among 2019 Most Influential Corporate Directors by WomenInc. Magazine

LAFAYETTE, Ind., Dec. 11, 2019 (GLOBE NEWSWIRE) — WomenInc. Magazine has recognized Wabash National Corporation (NYSE: WNC) Board member Ann Murtlow for her leadership on corporate boards and distinguished professional accomplishments.“Congratulations to Ann for this well-deserved acknowledgment of her contributions not only to Wabash National but to all of the organizations she serves,” said Brent Yeagy, president and CEO. “At Wabash National, we strive to be a company that is driven by a diverse and inclusive community of passionate people working together to fulfill our purpose of changing how the world reaches you. Our customers and our shareholders benefit from leaders like Ann who bring different experiences, knowledge and points of view that make our company better.”Murtlow, who is President and Chief Executive Officer of...

Continue reading

Dolby Presents Dolby Atmos Music and Post Malone, Exploring What Drives His Creativity and Desire to Connect with Fans

SAN FRANCISCO, Dec. 11, 2019 (GLOBE NEWSWIRE) — Today, Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, is unveiling the third short film of its Dolby Atmos Music campaign featuring global superstar, Post Malone, one of 2019’s most streamed artists.“For the next stop on our journey to redefine music, we take a ride with Post Malone to share his creative process and reaction to experiencing his own music in Dolby Atmos for the first time,” said Todd Pendleton, Senior Vice President and Chief Marketing Officer, Dolby Laboratories. “Post said it best, ‘I’ve never heard music like this.’”Spotlighting his latest hit Circles, which has been one of the top songs on Billboard’s Hot 100 Chart, the film explores Post Malone’s desire to connect with people through music and the journey behind his rise...

Continue reading

Explor – Annual and Special Meeting of Shareholders

ROUYN-NORANDA, Quebec, Dec. 11, 2019 (GLOBE NEWSWIRE) — Explor Resources Inc. (TSX-V: EXS, OTCPK: EXSFF, FSE & BE: E1H1) (« Explor » or the « Corporation ») is pleased to announce that at the Annual and Special Meeting of Shareholders held on December 11, 2019, the following directors were elected: Christian Dupont of New Brunswick, Geoffrey Carter of Ontario, Mario Colantonio of Ontario and Gerhard Merkel of Germany.The accounting firm Dallaire & Lapointe Inc. was re-appointed as independent auditors. The shareholders have also approved the continuation of the Corporation’s Stock Option Plan and of the Shareholder Rights Plan. The shareholders also approved the special resolution approving the amalgamation with Pure Nickel Inc.  It is expected that the Amalgamation will be effective in the coming weeks; a press release...

Continue reading

Explor – Assemblée annuelle et extraordinaire des actionnaires

ROUYN-NORANDA, Québec, 11 déc. 2019 (GLOBE NEWSWIRE) — Ressources Explor inc.  (Bourse de croissance TSX ; EXS, OTCPK : EXSFF, FSE : E1H1) (« Explor » ou la « Société ») est heureuse d’annoncer que suite à l’assemblée annuelle et extraordinaire des actionnaires tenue le 11 décembre 2019, les administrateurs suivants ont été élus : Christian Dupont du Nouveau-Brunswick, Geoffrey Carter de l’Ontario, Mario Colantonio de l’Ontario et Gerhard Merkel d’Allemagne.La firme Dallaire & Lapointe Inc. a été reconduite en tant qu’auditeurs indépendants de la Société. Les actionnaires ont également approuvé la continuation du régime d’options d’achat d’actions de la Société et du régime de droits des actionnaires. Les actionnaires ont également approuvé la résolution spéciale approuvant la fusion avec Pure Nickel Inc. Il est prévu que la...

Continue reading

Jeffersonville Bancorp Announces Special Dividend of $0.10 per share

JEFFERSONVILLE, N.Y., Dec. 11, 2019 (GLOBE NEWSWIRE) — Jeffersonville Bancorp, Inc. (OTCQB – JFBC) announced today that a special cash dividend in the amount of ten cents ($0.10) per share on the common stock of the company was declared at the December 10, 2019 meeting of the Board of Directors. The dividend is payable on December 31, 2019 to stockholders of record at the close of business on December 23, 2019.“The Company continues to perform very well due to low core funding costs and higher average loan levels,” said George W. Kinne, Jr., President and CEO. “The Board of Directors is pleased that with our positive results and strong capital position, they are able to reward our loyal shareholders with a special cash dividend.”Jeffersonville Bancorp is a one-bank holding company, which owns all the capital...

Continue reading

Desert Hope Treatment Center’s New CEO Refuses to Lead from Behind a Desk

LAS VEGAS, Dec. 11, 2019 (GLOBE NEWSWIRE) — Desert Hope Treatment Center’s New CEO, Derek Price, isn’t the traditional executive. He doesn’t believe in wearing a suit or spending countless hours behind a desk. Instead, he spends the majority of his time connecting directly with patients, including eating lunch and dinner with them every day.“For someone to check into Desert Hope, they are often at one of the lowest points in their life, and they don’t need to see someone up in an ivory tower wearing a three-piece suit trying to relate to them,” said Price. “If I’m at my desk for more than an hour a day, that’s not typical. I like to put on casual clothing and sit with patients. I want to hear their stories and learn what we can do to better serve them. You can’t get that connection sitting behind a desk. That’s the culture I want...

Continue reading

BIC: Change of Capital and Cancellation of Shares

BIC – Press ReleaseClichy – 11 December 2019                                              Change of Capital and Cancellation of SharesDuring its meeting held on 10 December 2019, the Board of Directors of SOCIETE BIC decided, as authorized by the Shareholders, to proceed to:a capital increase through the issuance of 22,520 new shares following exercise of share subscription options from 1st of November 2018 to 31 December 2018, a capital decrease through cancellation of 478,667 shares.Upon completion of these transactions, the share capital of SOCIETE BIC amounts to 173,933,156.80 euros divided into 45,532,240 shares of 3.82 euros each, fully paid-up.ContactsFor more information, please consult the corporate website: www.bicworld.com 2019/2020 Agenda  – All dates to be confirmed  About BIC BIC is a world leader in stationery, lighters...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.